Bayer Acquires Rights to Cytokinetics’ Heart Drug in Japan
FRANKFURT – On Tuesday, Bayer struck a collaboration deal with U.S. biotech firm Cytokinetics (NASDAQ: CYTK) to acquire certain rights […]
Bayer Acquires Rights to Cytokinetics’ Heart Drug in Japan Read More »
